ZA976117B - Pseudopolyrotaxanes. - Google Patents

Pseudopolyrotaxanes.

Info

Publication number
ZA976117B
ZA976117B ZA9706117A ZA976117A ZA976117B ZA 976117 B ZA976117 B ZA 976117B ZA 9706117 A ZA9706117 A ZA 9706117A ZA 976117 A ZA976117 A ZA 976117A ZA 976117 B ZA976117 B ZA 976117B
Authority
ZA
South Africa
Prior art keywords
pct
sec
numbers
date
pseudopolyrotaxanes
Prior art date
Application number
ZA9706117A
Other languages
English (en)
Inventor
Johannes Platzek
Heribert Schmitt-Willich
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA976117B publication Critical patent/ZA976117B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
ZA9706117A 1996-07-09 1997-07-09 Pseudopolyrotaxanes. ZA976117B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19629494A DE19629494A1 (de) 1996-07-09 1996-07-09 Pseudopolyrotaxane

Publications (1)

Publication Number Publication Date
ZA976117B true ZA976117B (en) 1998-03-04

Family

ID=7800474

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9706117A ZA976117B (en) 1996-07-09 1997-07-09 Pseudopolyrotaxanes.

Country Status (8)

Country Link
US (1) US6068831A (fr)
EP (1) EP0917474B1 (fr)
JP (1) JP2000514850A (fr)
AT (1) ATE229819T1 (fr)
AU (1) AU3344697A (fr)
DE (2) DE19629494A1 (fr)
WO (1) WO1998001163A2 (fr)
ZA (1) ZA976117B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19758118A1 (de) * 1997-12-17 1999-07-01 Schering Ag Polyrotaxane
AU2002246302A1 (en) * 2001-03-23 2002-10-08 University College Dublin Macrocyclic oligosaccharide derivatives which form manoscale assemblies
MX367615B (es) 2002-09-06 2019-08-28 Cerulean Pharma Inc Polimeros a base de ciclodextrina para el suministro de agentes terapeuticos.
EP1549269A4 (fr) * 2002-10-09 2010-10-06 Cerulean Pharma Inc Materiaux et compositions a base de cyclodextrine, et utilisations correspondantes
JP2007063412A (ja) * 2005-08-31 2007-03-15 Nissan Motor Co Ltd 親水性修飾ポリロタキサン及び架橋ポリロタキサン
JP4521875B2 (ja) * 2005-08-31 2010-08-11 日産自動車株式会社 疎水性修飾ポリロタキサン
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
CN102256628A (zh) * 2008-12-19 2011-11-23 鲁昂大学 用于mri成像的灵敏的造影剂
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
WO2014182804A1 (fr) 2013-05-07 2014-11-13 Purdue Research Foundation Compositions thérapeutiques et d'imagerie et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
JP3699141B2 (ja) * 1994-09-24 2005-09-28 伸彦 由井 超分子構造の生体内分解性医薬高分子集合体及びその調製方法
EP0766968B1 (fr) * 1995-10-06 2001-01-17 Nihon Medi-Physics Co., Ltd. Agent pour l'imagerie diagnostique

Also Published As

Publication number Publication date
AU3344697A (en) 1998-02-02
WO1998001163A2 (fr) 1998-01-15
EP0917474B1 (fr) 2002-12-18
JP2000514850A (ja) 2000-11-07
ATE229819T1 (de) 2003-01-15
WO1998001163A3 (fr) 1998-04-09
DE59709024D1 (de) 2003-01-30
EP0917474A2 (fr) 1999-05-26
US6068831A (en) 2000-05-30
DE19629494A1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
CA2371818A1 (fr) Complexes salicylamides lanthanides utilises comme marqueurs luminescents
GR3033827T3 (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
AU5488498A (en) Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
ATE172968T1 (de) Substituierte azadioxacycloalkene und ihre verwendung als fungizide
PL318297A1 (en) Dihydrobenzofuranes
AU3220595A (en) Metal complexes with charged linker
ES2143059T3 (es) Complejos metalicos hidrofilos.
ATE285394T1 (de) Phthalamid-lanthanid komplexe zur verwendung als lumineszenzmarker
TW263499B (fr)
CY2502B1 (en) Novel tetrazoles.
ZA976117B (en) Pseudopolyrotaxanes.
ATE207929T1 (de) Diastereomerenreine 3-oxo und 3-thioxo-4-aza- androstanderivate und ihre verwendung als antiandrogene
IL117209A (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
SI0989973T1 (sl) Halkoni z antiproliferativno aktivnostjo
NO972346D0 (no) Aminoguanidinkarboksylater for behandling av ikke-insulinavhengig diabetes millitus
TR199701716T1 (xx) Poliaminoasitlerin metal kompleksleri.
DE69410614T2 (de) Bis-naphthalimide für die behandlung von krebs
BG104232A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazozocyn-10-ols, method for their preparation and application as medicamentous forms
IL129329A0 (en) Chiral ferrocenyls
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
PL314797A1 (en) Hirudin conjugates from hirudin and lipophylic compounds
GB9410207D0 (en) Process
MY131703A (en) Complexes of the lanthanides with heterocyclic carbenes
MX9801130A (es) Tiamacrolidos.
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis